MYGN
Price:
$4.33
Market Cap:
$408.96M
Myriad Genetics, Inc. is a leading company specializing in genetic testing and precision medicine. The firm focuses on developing and marketing a wide array of genetic diagnostic solutions across both domestic U.S. and international landscapes. Their extensive diagnostic offerings cater to crucial medical fields, including oncology, women's health, and mental well-being. In cancer diagnostics, Myriad provides several sophisticated molecular tests. These include the MyRisk Hereditary Cancer Test, which uses DNA sequencing to evaluate an individual's susceptibility to inherited cancer types. The BRACAnalysis CDx functions as a vital companion diagnostic, leveraging DNA sequencing to inform tre...[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
1995-10-06
Stock Exchange
NASDAQ
Ticker
MYGN
According to Myriad Genetics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 496.06M. This represents a change of -19.15% compared to the average of 613.53M of the last 4 quarters.
The mean historical Enterprise Value of Myriad Genetics, Inc. over the last ten years is 1.58B. The current 496.06M Enterprise Value has changed 3.04% with respect to the historical average. Over the past ten years (40 quarters), MYGN's Enterprise Value was at its highest in in the September 2018 quarter at 3.29B. The Enterprise Value was at its lowest in in the March 2026 quarter at 508.75M.
Average
1.58B
Median
1.63B
Minimum
634.00M
Maximum
2.49B
Discovering the peaks and valleys of Myriad Genetics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 67.75%
Maximum Annual Enterprise Value = 2.49B
Minimum Annual Increase = -54.51%
Minimum Annual Enterprise Value = 634.00M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 634.00M | -50.47% |
| 2024 | 1.28B | -20.24% |
| 2023 | 1.60B | 27.64% |
| 2022 | 1.26B | -36.46% |
| 2021 | 1.98B | 20.02% |
| 2020 | 1.65B | 67.75% |
| 2020 | 982.86M | -54.51% |
| 2019 | 2.16B | -13.29% |
| 2018 | 2.49B | 41.46% |
| 2017 | 1.76B | -15.04% |
The current Enterprise Value of Myriad Genetics, Inc. (MYGN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
1.17B
5-year avg
1.35B
10-year avg
1.58B
Myriad Genetics, Inc.’s Enterprise Value is less than Castle Biosciences, Inc. (600.79M), less than Personalis, Inc. (816.82M), less than CareDx, Inc (1.13B), less than Fulgent Genetics, Inc. (517.29M), greater than DarioHealth Corp. (63.18M), less than AMN Healthcare Services, Inc. (1.41B), less than Vir Biotechnology, Inc. (1.26B), less than Evolent Health, Inc. (1.36B), less than Maravai LifeSciences Holdings, Inc. (2.49B), less than Ginkgo Bioworks Holdings, Inc. (782.25M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 600.79M | $627.83M | |
| 816.82M | $851.63M | |
| 1.13B | $1.19B | |
| 517.29M | $530.52M | |
| 63.18M | $51.63M | |
| 1.41B | $1.19B | |
| 1.26B | $1.45B | |
| 1.36B | $539.91M | |
| 2.49B | $1.38B | |
| 782.25M | $515.41M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Myriad Genetics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Myriad Genetics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Myriad Genetics, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Myriad Genetics, Inc. (MYGN)?
What is the 3-year average Enterprise Value for Myriad Genetics, Inc. (MYGN)?
What is the 5-year average Enterprise Value for Myriad Genetics, Inc. (MYGN)?
How does the current Enterprise Value for Myriad Genetics, Inc. (MYGN) compare to its historical average?